source
- Abivax’s ulcerative colitis Phase 3 trial shows promising efficacy but cancer cases raise safety concernsAbivax announced that its Phase 3 maintenance trial in ulcerative colitis produced results it called “landmark,” showing the drug’s ability to keep patients in remission. The company emphasized th…
- States tighten rules on corporate telehealth, targeting business structures behind direct-to-consumer careTelehealth has grown into a multibillion‑dollar industry, with brands like Hims & Hers and Teladoc becoming widely recognized. Despite their visibility, many patients are unaware that corporate te…